4//SEC Filing
Prentiss Christopher B 4
Accession 0001209191-19-055838
CIK 0001328143other
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 4:48 PM ET
Size
10.7 KB
Accession
0001209191-19-055838
Insider Transaction Report
Form 4
Prentiss Christopher B
Chief Accounting Officer
Transactions
- Award
Common Stock
2019-11-07+25,000→ 72,209 total - Award
Stock Option (Right to Buy)
2019-11-07+50,000→ 50,000 totalExercise: $4.70Exp: 2029-11-06→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest as follows: 1/4th on each of 11/1/20, 11/1/21, 11/1/22 and 11/1/23, subject to Reporting Person's Continuous Service as of each such date.
- [F2]The Option shares shall vest as follows: 1/48th of the option shares shall vest on December 1, 2019 and 1/48th shall vest monthly thereafter, subject to Reporting Person's Continuous Service as of each such date.
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeother
Related Parties
1- filerCIK 0001717583
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 4:48 PM ET
- Size
- 10.7 KB